Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 19 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 13 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

19Total
Not Applicable (3)
P 1 (16)

Trial Status

Completed13
Unknown3
Not Yet Recruiting3

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 13 completed trials

Clinical Trials (19)

Showing 19 of 19 trials
NCT06579053Phase 1CompletedPrimary

Bioequivalence Study of Spironolactone Tablets in Healthy Subjects

NCT06549504Phase 1Not Yet RecruitingPrimary

Bioequivalence Study of AG2202

NCT06441916Phase 1Not Yet Recruiting

Bioequivalence Study of Dabigatran Etexilate Capsules 150 mg in Healthy Thai Volunteers Under Fasting Conditions

NCT06273254Phase 1Not Yet RecruitingPrimary

A Bioequivalence Study of Sacubitril/Valsartan Film-coated Tablets Under Fasting Conditions

NCT04877834Phase 1Completed

Bioequivalence Study of DelanzoᵀᴹDR 60mg (Dexlansoprazole) Capsule With Dexilant® 60mg (Dexlansoprazole) Capsule in Healthy Pakistani Subjects.

NCT06058689Phase 1UnknownPrimary

A Pilot Bioequivalence Study of Pomalidomide

NCT05794919Not ApplicableUnknownPrimary

Bioequivalence Study of Calcium Hydroxybenzene Sulphonate Dispersible Tablets in Chinese Healthy Volunteers

NCT05436769Phase 1Completed

Bioequivalence Study of Klaribact (Clarithromycin) 500 mg, Film Coated Tablet

NCT04873570Phase 1Completed

Bioequivalence Study of Mofest® 400mg (Moxifloxacin) Tablet With Avelox® 400mg (Moxifloxacin) Tablet in Healthy Pakistani Subjects

NCT05436886Not ApplicableCompleted

Bioequivalence Study of Neurogabin-M (Gabapentin 400 mg) Capsule With Parketin (Gabapentin 400 mg) Capsules

NCT04585321Phase 1CompletedPrimary

Comparative Bioavailability and Local Tolerability of Two Topical Diclofenac Plasters Applied Once and Twice a Day

NCT04358770Phase 1CompletedPrimary

Bio-equivalence Vasoconstriction Activity Study for Topically Applied Clocortolone Pivalate 0.1% Cream

NCT03602300Phase 1CompletedPrimary

A Phase 1 Bioequivalence Study of a Test Tablet Formulation of Ravidasvir With the Reference Tablet Formulation of Ravidasvir Study

NCT04229602Not ApplicableUnknownPrimary

Bioequivalence Study of Venlafaxine Hydrochloride Sustained-Release Capsules in Chinese Healthy Volunteers

NCT03765944Phase 1CompletedPrimary

Bioequivalence Study of NPC-12 (Sirolimus) Granules and Tablets

NCT03050164Phase 1CompletedPrimary

Bioequivalence Study of Gefitinib Tablets Under Fasting Conditions

NCT02132897Phase 1CompletedPrimary

Fed Bioequivalence Study of CBZ Formulations

NCT01595425Phase 1CompletedPrimary

Bioequivalence Study Comparing D961H Sachet and D961H Capsule in Japanese Healthy Male Subjects

NCT01494402Phase 1CompletedPrimary

Study to Assess the Bioequivalence Between D961S and Esomeprazole/Buffered Acetylsalicylic Acid (ASA) in Japanese Healthy Male Subjects

Showing all 19 trials

Research Network

Activity Timeline